We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
NXP Semiconductors
NXPI
$68B
| $1.82M | 0.02% |
22,500
-20,608
| -48% | -$1.54M |
|
577
Shake Shack
SHAK
$2.3B
| $1.8M | 0.02% |
48,169
+37,457
| +350% | +$1.35M |
|
|
IPXL
578
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.8M | 0.02% |
56,090
-20,534
| -27% | -$722K |
|
579
Comfort Systems
FIX
$61B
| $1.79M | 0.02% |
+56,494
| New | +$1.6M |
|
|
RPTP
580
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $1.78M | 0.02% |
+386,825
| New | +$1.55M |
|
|
TFCFA
581
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.77M | 0.02% |
63,483
-1,332,458
| -95% | -$35.7M |
|
582
NiSource
NI
$22.4B
| $1.77M | 0.02% |
+75,020
| New | +$1.61M |
|
583
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $1.77M | 0.02% |
+36,024
| New | +$1.72M |
|
584
Bausch Health
BHC
$1.65B
| $1.76M | 0.02% |
67,054
+1,668
| +3% | +$123K |
|
585
Rigel Pharmaceuticals
RIGL
$680M
| $1.76M | 0.02% |
84,793
+12,180
| +17% | +$300K |
|
|
ALXN
586
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.74M | 0.02% |
12,481
-39,248
| -76% | -$5.76M |
|
587
lululemon athletica
LULU
$13B
| $1.72M | 0.02% |
25,424
+3,775
| +17% | +$227K |
|
588
Service Corp International
SCI
$11.4B
| $1.72M | 0.02% |
69,667
-119,573
| -63% | -$2.83M |
|
589
Zimmer Biomet
ZBH
$17.7B
| $1.72M | 0.02% |
16,607
-6,409
| -28% | -$620K |
|
|
VG
590
DELISTED
Vonage Holdings Corporation
VG
| $1.72M | 0.02% |
375,808
+359,959
| +2,271% | +$1.78M |
|
591
SBA Communications
SBAC
$18.4B
| $1.71M | 0.02% |
+17,098
| New | +$1.63M |
|
592
PVH
PVH
$3.71B
| $1.7M | 0.02% |
17,143
+9,413
| +122% | +$741K |
|
|
XXIA
593
DELISTED
Ixia
XXIA
| $1.69M | 0.02% |
+135,895
| New | +$1.44M |
|
594
Dollar General
DG
$25.9B
| $1.68M | 0.02% |
19,607
-4,162
| -18% | -$315K |
|
|
CBM
595
DELISTED
Cambrex Corporation
CBM
| $1.67M | 0.02% |
38,025
+28,977
| +320% | +$1.14M |
|
596
Terex
TEX
$7.98B
| $1.67M | 0.02% |
66,979
-33,021
| -33% | -$691K |
|
|
CALD
597
DELISTED
Callidus Software, Inc.
CALD
| $1.66M | 0.02% |
+99,748
| New | +$1.48M |
|
|
EFII
598
DELISTED
Electronics for Imaging
EFII
| $1.66M | 0.02% |
+39,178
| New | +$1.6M |
|
|
UFS
599
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.66M | 0.02% |
40,977
-17,054
| -29% | -$584K |
|
|
VNET
600
VNET Group
VNET
$2.05B
| $1.66M | 0.02% |
83,080
+51,505
| +163% | +$983K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.